• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌肺转移:101例患者的治疗结果

Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients.

作者信息

Samaan N A, Schultz P N, Haynie T P, Ordonez N G

出版信息

J Clin Endocrinol Metab. 1985 Feb;60(2):376-80. doi: 10.1210/jcem-60-2-376.

DOI:10.1210/jcem-60-2-376
PMID:3965495
Abstract

Well differentiated thyroid carcinoma was diagnosed in 1,127 patients at The University of Texas M.D. Anderson Hospital and Tumor Institute at Houston from 1951 to 1981. Of those 1,127 patients, 101 had documented pulmonary metastasis. A retrospective analysis was conducted, and these patients were followed up until 1983. The primary tumors in these patients were histologically classified as papillary (67%), follicular (22%), or Hurthle cell (11%). The age at diagnosis ranged from 5-87 yr. Lung metastasis was diagnosed by both chest x-ray and positive uptake of 131I in 49 patients. Forty-two patients had positive chest x-ray results and negative 131I scans, and 10 patients had positive 131I scans and negative chest x-ray results. The patients were treated with radioactive iodine (76%), chemotherapy (9%), external radiotherapy (2%), or supportive care only (14%). Sixty-seven patients subsequently died of thyroid carcinoma. Our studies showed the following. 1) Patients who were younger than 40 yr of age at diagnosis had better prognosis (71% survival) compared with those over 40 yr of age (16% survival; P less than 0.01). 2) Uptake of radioactive iodine by lung metastasis is a favorable prognostic factor, especially in patients with negative radiological findings. Patients treated with radioactive iodine have a longer survival than those not treated with radioactive iodine (P less than 0.002). 3) The incidence of pulmonary metastasis is significantly less in patients who are treated by total thyroidectomy than in those treated with less than total thyroidectomy (P less than 0.03). 4) The incidence of pulmonary metastasis is lowest in patients with papillary carcinoma (9%), compared with that in patients with follicular (13%) or Hurthle cell (25%) carcinoma.

摘要

1951年至1981年期间,德克萨斯大学MD安德森医院和休斯顿肿瘤研究所诊断出1127例高分化甲状腺癌患者。在这1127例患者中,101例有记录在案的肺转移。进行了回顾性分析,并对这些患者随访至1983年。这些患者的原发性肿瘤在组织学上分为乳头状(67%)、滤泡状(22%)或许特耳细胞(11%)。诊断时的年龄范围为5至87岁。49例患者通过胸部X光和131I阳性摄取诊断为肺转移。42例患者胸部X光结果阳性而131I扫描阴性,10例患者131I扫描阳性而胸部X光结果阴性。患者接受放射性碘治疗(76%)、化疗(9%)、外照射放疗(2%)或仅接受支持治疗(14%)。67例患者随后死于甲状腺癌。我们的研究显示如下:1)诊断时年龄小于40岁的患者预后较好(生存率71%),而40岁以上的患者预后较差(生存率16%;P<0.01)。2)肺转移摄取放射性碘是一个有利的预后因素,尤其是在放射学检查结果为阴性的患者中。接受放射性碘治疗的患者比未接受放射性碘治疗的患者生存期更长(P<0.002)。3)全甲状腺切除术治疗的患者肺转移发生率明显低于次全甲状腺切除术治疗的患者(P<0.03)。4)乳头状癌患者的肺转移发生率最低(9%),而滤泡状癌(13%)或许特耳细胞癌(25%)患者的肺转移发生率较高。

相似文献

1
Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients.分化型甲状腺癌肺转移:101例患者的治疗结果
J Clin Endocrinol Metab. 1985 Feb;60(2):376-80. doi: 10.1210/jcem-60-2-376.
2
Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.甲状腺嗜酸性细胞肿瘤患者的预后因素
Cancer. 2003 Mar 1;97(5):1186-94. doi: 10.1002/cncr.11176.
3
The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients.高分化甲状腺癌的各种治疗方式的结果:对1599例患者的回顾性研究
J Clin Endocrinol Metab. 1992 Sep;75(3):714-20. doi: 10.1210/jcem.75.3.1517360.
4
Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.诊断时伴有远处转移的乳头状和滤泡状(分化型)甲状腺癌的临床管理与预后
Cancer. 2007 Oct 1;110(7):1451-6. doi: 10.1002/cncr.22956.
5
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.放射性碘治疗及外照射放疗用于甲状腺癌肺和骨转移
J Nucl Med. 1996 Apr;37(4):598-605.
6
Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.甲状腺分化癌治疗的影响:706例病例分析
J Clin Endocrinol Metab. 1983 Jun;56(6):1131-8. doi: 10.1210/jcem-56-6-1131.
7
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
8
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.444例乳头状和滤泡状甲状腺癌远处转移患者的长期预后:放射性碘治疗的益处和局限性
J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9. doi: 10.1210/jc.2005-2838. Epub 2006 May 9.
9
Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.在诊断性 131I 全身扫描阴性但治疗后阳性的结构可识别转移性滤泡细胞来源甲状腺癌患者中,经验性放射性碘治疗后的临床结果。
Thyroid. 2012 Sep;22(9):877-83. doi: 10.1089/thy.2011.0429. Epub 2012 Jul 24.
10
Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma.碘-131治疗与高分辨率CT:分化型甲状腺癌肺转移患者的治疗结果
Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):825-30. doi: 10.1007/s00259-004-1460-x. Epub 2004 Feb 5.

引用本文的文献

1
Development and validation of a lung metastases-predicting nomogram for intermediate- to high-risk differentiated thyroid carcinoma patients.中高危分化型甲状腺癌患者肺转移预测列线图的开发与验证
Future Oncol. 2024;20(22):1575-1586. doi: 10.1080/14796694.2024.2354161. Epub 2024 Jun 13.
2
Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis.分化型甲状腺癌肺转移患者的生存预后因素:一项系统评价和荟萃分析。
Front Oncol. 2022 Dec 15;12:990154. doi: 10.3389/fonc.2022.990154. eCollection 2022.
3
Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis.
伴远处转移的间变性甲状腺癌的预后
Cancers (Basel). 2022 Nov 24;14(23):5784. doi: 10.3390/cancers14235784.
4
Treatment Response following Radioactive Iodine Therapy in Miliary versus Macronodular Pulmonary Metastases in Papillary Thyroid Carcinoma.分化型甲状腺癌粟粒性与大结节性肺转移放射性碘治疗后的疗效反应
World J Nucl Med. 2022 Apr 30;21(1):52-58. doi: 10.1055/s-0042-1746175. eCollection 2022 Mar.
5
Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United States.仑伐替尼及后续治疗在放射性碘难治性分化型甲状腺癌中的应用:美国真实世界研究中的临床疗效。
Adv Ther. 2020 Jun;37(6):2841-2852. doi: 10.1007/s12325-020-01362-6. Epub 2020 May 7.
6
Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers.分化型甲状腺癌诊断与管理中的当前争议及未来方向
Gland Surg. 2018 Oct;7(5):473-486. doi: 10.21037/gs.2017.09.08.
7
Clinical characteristics and disease outcome of patients with non-medullary thyroid cancer and brain metastases.非髓样甲状腺癌伴脑转移患者的临床特征与疾病转归
Oncol Lett. 2018 Jan;15(1):672-676. doi: 10.3892/ol.2017.7325. Epub 2017 Nov 1.
8
External Beam Radiation in Differentiated Thyroid Carcinoma.分化型甲状腺癌的外照射放疗
Rambam Maimonides Med J. 2016 Jan 28;7(1):e0008. doi: 10.5041/RMMJ.10235.
9
Changes in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer.分化型甲状腺癌肺转移患者放射性碘治疗后肺功能测试的变化
PLoS One. 2015 Apr 29;10(4):e0125114. doi: 10.1371/journal.pone.0125114. eCollection 2015.
10
Improved detection of lung or bone metastases with an I-131 whole body scan on the 7th day after high-dose I-131 therapy in patients with thyroid cancer.甲状腺癌患者在接受大剂量 I - 131 治疗后第 7 天进行 I - 131 全身扫描可提高对肺或骨转移的检测率。
Nucl Med Mol Imaging. 2010 Dec;44(4):273-81. doi: 10.1007/s13139-010-0051-y. Epub 2010 Oct 13.